NEW YORK (GenomeWeb News) – Sequenom has licensed exclusive worldwide rights, except for Hong Kong, to intellectual property covering digital PCR and other non-invasive prenatal diagnostic technology from the Chinese University of Hong Kong.
 
The license expands San Diego-based Sequenom’s IP portfolio covering prenatal diagnostic methods using fetal nucleic acids obtained from maternal samples.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.